Table 1.
Correlation between SPRY4-IT1 expression and clinicopathological features of UCB patients
| Parameters | Group | Total | SPRY4-IT1 expression | P value | |
|---|---|---|---|---|---|
|
| |||||
| High | Low | ||||
| Gender | Male | 38 | 22 | 16 | 0.707 |
| Female | 30 | 16 | 14 | ||
| Age (years) | < 59 | 42 | 24 | 18 | 0.790 |
| ≥ 59 | 26 | 14 | 12 | ||
| Tumor size (cm) | < 3 cm | 37 | 21 | 16 | 0.874 |
| ≥ 3 cm | 31 | 17 | 14 | ||
| Multiplicity | Single | 42 | 23 | 19 | 0.813 |
| Multiple | 26 | 15 | 11 | ||
| Histological grade | G1 | 27 | 7 | 20 | 0.000 |
| G2, G3 | 41 | 31 | 10 | ||
| Tumor stage | Ta, T1 | 32 | 13 | 19 | 0.017 |
| T2, T3, T4 | 36 | 25 | 11 | ||
| Lymph nodes metastasis | No | 49 | 20 | 29 | 0.000 |
| Yes | 19 | 18 | 1 | ||